What is Chrysalis ABA?
Chrysalis ABA is a dedicated provider of Applied Behavior Analysis (ABA) therapy, committed to enhancing the lives of individuals diagnosed with Autism Spectrum Disorder (ASD) and other developmental challenges. The company distinguishes itself through the delivery of highly personalized treatment plans, executed via intensive one-on-one sessions. A key aspect of their approach involves robust caregiver training and a focus on developing essential life skills, including effective communication, managing food aversions, toilet training, and academic tutoring. Chrysalis ABA's operational model prioritizes the highest standards of therapeutic care, aiming to foster greater independence and improved quality of life for its diverse client base.
How much funding has Chrysalis ABA raised?
Chrysalis ABA has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Chrysalis ABA
PPP
Public-Private Partnership
What's next for Chrysalis ABA?
The substantial late-stage investment Chrysalis ABA has received signals a strategic pivot towards significant scaling and market penetration. This capital infusion is likely earmarked for expanding service offerings, enhancing technological infrastructure for therapy delivery, and potentially broadening geographic reach. Future developments may include strategic partnerships with healthcare providers or educational institutions to further integrate ABA services. The company's focus on specialized therapy for developmental disabilities positions it to capitalize on growing demand for evidence-based interventions, with this latest financing providing the necessary resources to accelerate growth and solidify its market leadership.
See full Chrysalis ABA company page
